These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20179636)

  • 1. Oral beclomethasone dipropionate in pediatric active ulcerative colitis: a comparison trial with mesalazine.
    Romano C; Famiani A; Comito D; Rossi P; Raffa V; Fries W
    J Pediatr Gastroenterol Nutr; 2010 Apr; 50(4):385-9. PubMed ID: 20179636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study.
    Biancone L; Gionchetti P; Blanco Gdel V; Orlando A; Annese V; Papi C; Sostegni R; D'Incà R; Petruzziello C; Casa A; Sica G; Calabrese E; Campieri M; Pallone F
    Dig Liver Dis; 2007 Apr; 39(4):329-37. PubMed ID: 17347061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beclomethasone dipropionate (3 mg) enemas combined with oral 5-ASA (2.4 g) in the treatment of ulcerative colitis not responsive to oral 5-ASA alone.
    D'Arienzo A; Manguso F; Castiglione GN; Vicinanza G; Scaglione G; Bennato R; Sanges M; Mazzacca G
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):254-7. PubMed ID: 9759590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: the efficacy of rectal beclomethasone dipropionate vs. 5-aminosalicylic acid in mild to moderate distal ulcerative colitis.
    Manguso F; Balzano A
    Aliment Pharmacol Ther; 2007 Jul; 26(1):21-9. PubMed ID: 17555418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Zhao X; Li N; Ren Y; Ma T; Wang C; Wang J; You S
    PLoS One; 2016; 11(8):e0160500. PubMed ID: 27501314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Manguso F; Bennato R; Lombardi G; Riccio E; Costantino G; Fries W
    PLoS One; 2016; 11(11):e0166455. PubMed ID: 27846307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randomized controlled trial.
    Gionchetti P; D'Arienzo A; Rizzello F; Manguso F; Maieron R; Lecis PE; Valpiani D; Iaquinto G; Annese V; Balzano A; Varoli G; Campieri M;
    J Clin Gastroenterol; 2005 Apr; 39(4):291-7. PubMed ID: 15758622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations.
    Lichtenstein GR; Kamm MA; Sandborn WJ; Lyne A; Joseph RE
    Aliment Pharmacol Ther; 2008 Jun; 27(11):1094-102. PubMed ID: 18363894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled study.
    Bossa F; Latiano A; Rossi L; Magnani M; Palmieri O; Dallapiccola B; Serafini S; Damonte G; De Santo E; Andriulli A; Annese V
    Am J Gastroenterol; 2008 Oct; 103(10):2509-16. PubMed ID: 18721243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: the RECLICU Study.
    Nunes T; Barreiro-de Acosta M; Nos P; Marin-Jiménez I; Bermejo F; Ceballos D; Iglesias E; Gomez-Senent S; Torres Y; Ponferrada A; Arevalo JA; Hernandez V; Calvet X; Ginard D; Monfort D; Chaparro M; Manceñido N; Domínguez-Antonaya M; Villalón C; Perez-Calle JL; Muñoz C; Nuñez H; Carpio D; Aramendiz R; Bujanda L; Estrada-Oncins S; Hermida C; Barrio J; Casis MB; Dueñas-Sadornil MC; Fernández L; Calvo-Cenizo MM; Botella B; de Francisco R; Ayala E; Sans M;
    J Crohns Colitis; 2010 Dec; 4(6):629-36. PubMed ID: 21122572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
    Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
    Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.
    Hanauer S; Schwartz J; Robinson M; Roufail W; Arora S; Cello J; Safdi M
    Am J Gastroenterol; 1993 Aug; 88(8):1188-97. PubMed ID: 8338086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of clinical patterns in ulcerative colitis: a long-term follow-up.
    Bresci G; Parisi G; Gambardella L; Banti S; Bertoni M; Rindi G; Capria A
    Int J Clin Pharmacol Res; 1997; 17(1):17-22. PubMed ID: 9403349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis.
    Hartmann F; Stein J;
    Aliment Pharmacol Ther; 2010 Aug; 32(3):368-76. PubMed ID: 20491741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis.
    Sinha A; Nightingale J; West KP; Berlanga-Acosta J; Playford RJ
    N Engl J Med; 2003 Jul; 349(4):350-7. PubMed ID: 12878742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up.
    Bresci G; Parisi G; Mazzoni A; Scatena F; Capria A
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1678-82. PubMed ID: 18823440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study.
    Rizzello F; Gionchetti P; D'Arienzo A; Manguso F; Di Matteo G; Annese V; Valpiani D; Casetti T; Adamo S; Prada A; Castiglione GN; Varoli G; Campieri M
    Aliment Pharmacol Ther; 2002 Jun; 16(6):1109-16. PubMed ID: 12030952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with Asacol.
    Prantera C; Kohn A; Campieri M; Caprilli R; Cottone M; Pallone F; Savarino V; Sturniolo GC; Vecchi M; Ardia A; Bellinvia S
    Aliment Pharmacol Ther; 2009 Nov; 30(9):908-18. PubMed ID: 19678813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
    Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F
    Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.